| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000000776 |
| Receipt No. | R000000935 |
| Official scientific title of the study | Randomized controlled trial of antibiotic prophylaxis in elective laparoscopic colorectal surgery: Oral and systemic versus systemic antibiotics |
| Date of disclosure of the study information | 2007/08/01 |
| Last modified on | 2017/08/02 (Ver. 14) |
| Basic information | ||
| Official scientific title of the study | Randomized controlled trial of antibiotic prophylaxis in elective laparoscopic colorectal surgery: Oral and systemic versus systemic antibiotics | |
| Title of the study (Brief title) | Randomized controlled trial of antibiotic prophylaxis in elective laparoscopic colorectal surgery: Oral and systemic versus systemic antibiotics | |
| Region |
|
|
| Condition | |||
| Condition | Colorectal tumor with planned elective laparoscopic resection | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To determine optimal prophylactic antibiotic administration method in elective laparoscopic colorectal surgery |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Incidence and classification of surgical site infection (SSI) |
| Key secondary outcomes | Incidence of colitis, other infectious diseases and other postoperative complications. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is considered as adjustment factor in dynamic allocation. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intravenous dose of 1g cefmetazole just before surgery and additional doses every 3hs during surgery | |
| Interventions/Control_2 | 2 doses of oral kanamycin(1g)/ metronidazole(750mg) administration on the day before surgery with intravenous dose of 1g cefmetazole just before surgery and additional doses every 3hs during surgery | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Colorectal tumor(cancer, adenoma and suspected cases) with planned elective laparoscopic colorectal resection | |||
| Key exclusion criteria | 1) ECOG Performance Status >=2
2) Age<20 3) Any organ dysfunction 4) Ileus 5) Preoperative infectious disease 6) Antibiotic administration before surgery 7) Steroid administration before surgery 8) Neo-adjuvant radiation and/or chemo therapy 9) Diabetes mellitus 10) Pregnancy/lactational woman 11) Severe allergy |
|||
| Target sample size | 580 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroaki Hata |
| Organization | National Hospital Organization, Kyoto Medical Center |
| Division name | Surgery Division |
| Address | 1-1, Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto |
| TEL | 075-641-9161 |
| hhata-kyt@umin.ac.jp | |
| Public contact | |
| Name of contact person | Hiroaki Hata |
| Organization | National Hospital Organization, Kyoto Medical Center |
| Division name | Surgery Division |
| Address | 1-1, Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto |
| TEL | 075-641-9161 |
| Homepage URL | |
| hhata@kyotolan.hosp.go.jp | |
| Sponsor | |
| Institute | The Japan-Multinational Trial Organization(JMTO) |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | NCT00508690 |
| Org. issuing International ID_1 | ClinicalTrials.gov |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | https://www.ncbi.nlm.nih.gov/pubmed/26756752 |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000000935 |